Overview

Cognitive REmediation After Trauma Exposure Trial = CREATE Trial

Status:
Terminated

Trial end date:
2013-03-01

Target enrollment:

Participant gender:

Summary

This study will evaluate the efficacy of methylphenidate and galantamine in the treatment of persistent cognitive symptoms associated with posttraumatic stress disorder (PTSD) and/or traumatic brain injury (TBI).

Phase:

Phase 2

Details

Lead Sponsor:

INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium

Collaborators:

U.S. Army Medical Research and Development Command
U.S. Army Medical Research and Materiel Command

Treatments:

Galantamine
Methylphenidate